Advances in the Treatment of Myelodysplastic Syndrome: Targeting CD47

Naval Daver, MD, explains myelodysplastic syndrome, including risk factors and potential complications.

A key opinion leader describes how myelodysplastic syndrome is diagnosed, the typical presenting symptoms, and the methods of risk assessment.

Naval Daver, MD, illustrates the goals of treatment and treatment options for low-risk myelodysplastic syndrome.

An expert details the treatment options for high-risk myelodysplastic syndrome.

Dr. Naval Daver provides insight on the emerging first-line treatment options for high-risk myelodysplastic syndrome and breaks down clinical trial data.

An oncologist discusses the future of myelodysplastic syndrome, including upcoming studies and potential treatments.